Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewL-(-)-threo-3-Hydroxyaspartic acid is a potent, competitive, transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor. In [3H]-d-Asp uptake assays in HEK293 cells expressing human EAAT1, EAAT2 and EAAT3, Ki values are 11, 19, and 14 μM, respectively. In a FLIPR Membrane Potential (FMP) assay, Km values are 3.6, 3.8 and 3.2 μM for human EAAT1, EAAT2 and EAAT3, respectively.
M. Wt | 149.1 |
Formula | C4H7NO5 |
Storage | Store at RT |
Purity | ≥98% (HPLC) |
CAS Number | 7298-99-9 |
PubChem ID | 443239 |
InChI Key | YYLQUHNPNCGKJQ-LWMBPPNESA-N |
Smiles | [H][C@@]([C@]([H])(O)C(O)=O)(N)C(O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
1eq. NaOH | 100 |
The following data is based on the product molecular weight 149.1. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 6.71 mL | 33.53 mL | 67.07 mL |
5 mM | 1.34 mL | 6.71 mL | 13.41 mL |
10 mM | 0.67 mL | 3.35 mL | 6.71 mL |
50 mM | 0.13 mL | 0.67 mL | 1.34 mL |
References are publications that support the biological activity of the product.
Johnston et al (1980) Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stereoisomers of threo-3-hydroxyaspartate. J.Neurochem. 34 241 PMID: 7452241
McBean and Roberts (1985) Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum. J.Neurochem. 44 247 PMID: 2856883
Nakamura et al (1993) (2S,3S,4R)-2-(carboxycyclopropyl)glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate. Neuropharmacology 32 833 PMID: 7901789
Jensen and Bräuner-Osborne (2004) Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay. Biochem.Pharmacol. 67 2115 PMID: 15135308
If you know of a relevant reference for L-(-)-threo-3-Hydroxyaspartic acid, please let us know.
Keywords: L-(-)-threo-3-Hydroxyaspartic acid, L-(-)-threo-3-Hydroxyaspartic acid supplier, potent, competitive, Transportable, EAAT1, EAAT2, EAAT3, EAAT4, EAAT1-4, inhibitors, inhibits, non-transportable, EAAT5, Excitatory, Amino, Acid, Transporters, GLAST, GLT-1, Glutamate, Monoamine, Neurotransmitter, reuptake, L-threo-beta-Hydroxyaspartic, acid, L-threo-b-Hydroxyaspartic, 0183, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for L-(-)-threo-3-Hydroxyaspartic acid include:
Nakade et al (2018) Gut microbiota-derived D-serine protects against acute kidney injury. JCI Insight 3 PMID: 30333299
Do you know of a great paper that uses L-(-)-threo-3-Hydroxyaspartic acid from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review L-(-)-threo-3-Hydroxyaspartic acid and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.